HCAT vs. MOMO, FSLY, GDYN, MGIC, DAVA, EVER, BLND, DSP, DCBO, and HUYA
Should you be buying Health Catalyst stock or one of its competitors? The main competitors of Health Catalyst include Hello Group (MOMO), Fastly (FSLY), Grid Dynamics (GDYN), Magic Software Enterprises (MGIC), Endava (DAVA), EverQuote (EVER), Blend Labs (BLND), Viant Technology (DSP), Docebo (DCBO), and HUYA (HUYA). These companies are all part of the "computer software" industry.
Health Catalyst vs. Its Competitors
Hello Group (NASDAQ:MOMO) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations.
Hello Group has higher revenue and earnings than Health Catalyst. Health Catalyst is trading at a lower price-to-earnings ratio than Hello Group, indicating that it is currently the more affordable of the two stocks.
In the previous week, Health Catalyst had 4 more articles in the media than Hello Group. MarketBeat recorded 6 mentions for Health Catalyst and 2 mentions for Hello Group. Hello Group's average media sentiment score of 0.39 beat Health Catalyst's score of 0.02 indicating that Hello Group is being referred to more favorably in the media.
51.0% of Hello Group shares are owned by institutional investors. Comparatively, 85.0% of Health Catalyst shares are owned by institutional investors. 61.4% of Hello Group shares are owned by insiders. Comparatively, 2.6% of Health Catalyst shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Hello Group presently has a consensus target price of $9.00, suggesting a potential upside of 5.76%. Health Catalyst has a consensus target price of $8.00, suggesting a potential upside of 100.50%. Given Health Catalyst's stronger consensus rating and higher possible upside, analysts plainly believe Health Catalyst is more favorable than Hello Group.
Hello Group has a net margin of 9.36% compared to Health Catalyst's net margin of -23.34%. Hello Group's return on equity of 15.51% beat Health Catalyst's return on equity.
Hello Group has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500.
Summary
Hello Group beats Health Catalyst on 9 of the 16 factors compared between the two stocks.
Get Health Catalyst News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding HCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Health Catalyst Competitors List
Related Companies and Tools
This page (NASDAQ:HCAT) was last updated on 7/10/2025 by MarketBeat.com Staff